May 2020 PMID 31916006

Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.

Ronald Chow, Crystal Valdez, Natalie Chow, Daniel Zhang, James Im, Emily Sodhi, Michael Lock

Download social card

Mentions

5
Peak: 3 in Jan 2020
across 2 sources since Jan 2020

Extended reach

121,899
potential audience

Total likes

9,918

Video views

117,890

Mentions per month

Jan 2020 – Mar 2022

Where it's discussed

  • X / Twitter3 posts
  • YouTube2 videos

AI synopsis

What people are saying

The discussions reflect a cautious attitude towards the publication, with phrases like 'More opinion than data' and references to limited evidence. The tone indicates skepticism about claims of efficacy, emphasizing the need for stronger research before drawing firm conclusions, which influences the moderate agreement and low engagement scores.

AgreementNeither agree nor disagree

The discussions show skepticism about the strength of evidence, with one post suggesting there's more opinion than concrete data.

InterestModerate interest

There is a moderate level of interest, primarily due to curiosity about the therapeutic implications of cannabinoids.

EngagementLow engagement

Most comments are brief and dismissive, indicating superficial engagement rather than deep analysis.

ImpactNeutral impact

The discussions suggest limited perceived impact, as the comments highlight the lack of solid evidence and quality data.

Abstract in brief

  • This systematic review and meta-analysis examined whether oral cannabinoids are effective and safe for preventing chemotherapy-induced nausea and vomiting (CINV), finding they are more effective than placebo or other antiemetics in controlling nausea and vomiting.
  • The evidence suggests oral cannabinoids have similar efficacy to existing treatments, but they are associated with side effects such as dysphoria, euphoria, and sedation.
  • Despite some physiological basis for cannabinoids helping with CINV, current research from randomized controlled trials is limited, inconsistent in reporting, and does not definitively confirm their superiority or safety.]

Top posts

Most liked on X and Bluesky
Raffaele Giusti
@oncoblogger · X

More opionion than data: Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting https://t.co/UysT11fE6c

Jan 8, 2020 · 1 share · 1,512 followers View post →
Cancer Library VCC
@VCCLibrary · X

Oral cannabinoid for the prophylaxis of #chemotherapy-induced #nausea and vomiting—a systematic review and meta-analysis https://t.co/y1BtXpjJ3y #cancer

Jan 10, 2020 · 1,281 followers View post →

All mentions

Cancer Library VCC
@VCCLibrary · X

Oral cannabinoid for the prophylaxis of #chemotherapy-induced #nausea and vomiting—a systematic review and meta-analysis https://t.co/y1BtXpjJ3y #cancer

Jan 10, 2020 · 1,281 followers View post →
Garbiñe Lizeaga
@GarbineLizeaga · X

RT @oncoblogger: More opionion than data: Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting https://t.co/Uys…

Jan 8, 2020 · 1 share · 1,213 followers View post →
Raffaele Giusti
@oncoblogger · X

More opionion than data: Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting https://t.co/UysT11fE6c

Jan 8, 2020 · 1 share · 1,512 followers View post →